Ranch Capital Advisors Inc. Medtronic PLC Transaction History

Ranch Capital Advisors Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$82.84 - $88.09 $15,573 - $16,560	188 Added 2.04%	9,382 $817,000
Q4 2023 Feb 14, 2024	BUY	$69.43 - $83.43 $35,131 - $42,215	506 Added 5.82%	9,194 $757,000
Q3 2023 Nov 13, 2023	SELL	$78.22 - $90.4 $77,594 - $89,676	-992 Reduced 10.25%	8,688 $680,000
Q2 2023 Aug 11, 2023	SELL	$79.47 - $91.38 $8,344 - $9,594	-105 Reduced 1.07%	9,680 $852,000
Q1 2023 May 12, 2023	BUY	$76.72 - $87.58 $750,705 - $856,970	9,785 New	9,785 $788,000
Q4 2021 Feb 08, 2022	SELL	$99.53 - $127.75 $9,654 - $12,391	-97 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$122.75 - $135.17 $122 - $135	1 Added 1.04%	97 $12,000
Q2 2021 Aug 16, 2021	SELL	$118.19 - $131.5 $1,772 - $1,972	-15 Reduced 13.51%	96 $12,000
Q3 2020 Nov 16, 2020	SELL	$90.13 - $108.78 $6,489 - $7,832	-72 Reduced 39.34%	111 $11,000
Q2 2020 Aug 12, 2020	SELL	$84.11 - $103.33 $12,195 - $14,982	-145 Reduced 44.21%	183 $18,000
Q1 2020 May 12, 2020	SELL	$72.92 - $121.3 $8,677 - $14,434	-119 Reduced 26.62%	328 $29,000
Q4 2019 Feb 13, 2020	BUY	$104.49 - $114.54 $46,707 - $51,199	447 New	447 $51,000

2,286

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $114B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Ranch Capital Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Ranch Capital Advisors Inc. with notifications on news.